Cencora, Inc. COR

306.92 (2.95) (0.95%) as of 25 Sep
Market cap
$59.1B
P/E
22.7×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

Cencora, Inc. (COR) P/B ratio

As of 25 September 2026, Cencora, Inc. (COR) trades at a P/B ratio of 18.3×. Over the past ten years it has ranged from 0.0× (June 2021) to 509× (December 2022); the current reading is higher than 56% of that period. That is above the Healthcare sector median of 2.5×.

P/B ratio, daily

Annual

Period P/B ratio Change
FY2025 34.7× (38.95%)
FY2024 56.8× 4.34%
FY2023 54.4× (86.25%)
FY2022 396× 840.49%
FY2021 42.1× —
FY2020 0.0× —
FY2019 5.8× (12.79%)
FY2018 6.6× (24.77%)
FY2017 8.8× 9.46%
FY2016 8.1× (76.01%)

Quarterly

Period P/B ratio Change
Jun 2026 16.9× (1.02%)
Mar 2026 17.0× (45.53%)
Dec 2025 31.3× (9.73%)
Sep 2025 34.7× 31.84%
42 more quarters

Against its own ten years

Low 0.0× High 509×
Ten-year median 13.9×
Current reading's percentile 56

P/B ratio against peers

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on COR